Littelfuse Inc (LFUS) investors sentiment decreased to 1.21 in 2019 Q2. It’s down -0.04, from 1.25 in 2019Q1. The ratio worsened, as 128 investment professionals increased or started new holdings, while 106 sold and decreased their holdings in Littelfuse Inc. The investment professionals in our database now hold: 23.52 million shares, up from 22.95 million shares in 2019Q1. Also, the number of investment professionals holding Littelfuse Inc in top ten holdings decreased from 3 to 0 for a decrease of 3. Sold All: 19 Reduced: 87 Increased: 93 New Position: 35.
The stock of Editas Medicine, Inc. (NASDAQ:EDIT) is a huge mover today! The stock increased 4.28% or $1.25 during the last trading session, reaching $30.48. About 824,720 shares traded or 17.56% up from the average. Editas Medicine, Inc. (NASDAQ:EDIT) has declined 14.14% since November 29, 2018 and is downtrending. It has underperformed by 14.14% the S&P500. Some Historical EDIT News: 21/04/2018 – DJ Editas Medicine Inc, Inst Holders, 1Q 2018 (EDIT); 18/05/2018 – Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates; 03/05/2018 – EDITAS 1Q LOSS/SHR 67C, EST. LOSS/SHR 82C; 15/05/2018 – Editas Presenting at Conference Tomorrow; 28/03/2018 – Editas Medicine Names James C. Mullen as Chmn of Bd of Directors; 06/03/2018 – EDITAS MEDICINE INC – YEAR-END CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $329 MLN EXPECTED TO FUND BUSINESS FOR AT LEAST 24 MONTHS; 28/03/2018 – EDITAS MEDICINE INC – ALEXIS BORISY AND JOHN MENDLEIN, STEPPED DOWN FROM BOARD; 03/05/2018 – Editas Medicine 1Q Loss/Shr 67c; 14/05/2018 – Editas Presenting at Bank of America Conference Tomorrow; 06/03/2018 – Editas Medicine 4Q Loss/Shr 84cThe move comes after 8 months positive chart setup for the $1.56B company. It was reported on Nov, 29 by Barchart.com. We have $32.00 PT which if reached, will make NASDAQ:EDIT worth $78.20 million more.
More notable recent Editas Medicine, Inc. (NASDAQ:EDIT) news were published by: Nasdaq.com which released: “Why Editas Medicine Shares Jumped Today – Nasdaq” on November 25, 2019, also Nasdaq.com with their article: “Is CRISPR Therapeutics the Best Gene-Editing Stock Right Now? – Nasdaq” published on November 26, 2019, Nasdaq.com published: “Editas Medicine (EDIT) Reports Q3 Loss, Misses Revenue Estimates – Nasdaq” on November 12, 2019. More interesting news about Editas Medicine, Inc. (NASDAQ:EDIT) were released by: Nasdaq.com and their article: “CRISPR vs. Gene Therapy Round 1: What Investors Need to Know – Nasdaq” published on November 26, 2019 as well as Nasdaq.com‘s news article titled: “Editas Medicine (EDIT) in Focus: Stock Moves 7.8% Higher – Nasdaq” with publication date: November 20, 2019.
Analysts await Editas Medicine, Inc. (NASDAQ:EDIT) to report earnings on February, 27. They expect $0.04 EPS, up 107.69% or $0.56 from last year’s $-0.52 per share. EDIT’s profit will be $2.05 million for 190.50 P/E if the $0.04 EPS becomes a reality. After $-0.66 actual EPS reported by Editas Medicine, Inc. for the previous quarter, Wall Street now forecasts -106.06% EPS growth.
Editas Medicine, Inc. operates as a genome editing company. The company has market cap of $1.56 billion. It focuses on treating patients with genetically defined diseases by correcting their disease causing genes. It currently has negative earnings. It is developing a proprietary genome editing platform based on CRISPR technology to target genetically defined diseases with an initial focus on debilitating illnesses where there are no approved treatments.
Littelfuse, Inc. designs, manufactures, and sells circuit protection devices worldwide. The company has market cap of $4.45 billion. It operates through three divisions: Electronics, Automotive, and Industrial. It has a 30.61 P/E ratio. The Electronics segment provides fuses and protectors, positive temperature coefficient resettable fuses, resettable fuses, polymer electrostatic discharge suppressors, discrete transient voltage suppression diodes, TVS diode arrays protection and switching thyristors, gas discharge tubes, power switching components, fuseholders, reed switch and sensor assemblies, insulated gate bipolar transistors blocks, and related accessories.
Since January 1, 0001, it had 3 insider buys, and 0 sales for $35,838 activity.
The stock decreased 1.01% or $1.86 during the last trading session, reaching $182.69. About 6,360 shares traded. Littelfuse, Inc. (LFUS) has declined 22.54% since November 29, 2018 and is downtrending. It has underperformed by 22.54% the S&P500. Some Historical LFUS News: 02/05/2018 – Littelfuse 1Q Net $36M; 02/05/2018 – LITTELFUSE SEES 2Q ADJ EPS $2.39 TO $2.53, EST. $2.21; 02/05/2018 – Littelfuse Sees FY18 Adj Effective Tax Rate 18%-21%; 23/05/2018 – Littelfuse Honors Arrow Electronics as 2017 Volume Distributor of the Year; 14/03/2018 – Littelfuse Management Roadshow Scheduled By CL King for Mar. 21; 02/05/2018 – Littelfuse Sees 2Q Adj EPS $2.39-Adj EPS $2.53; 02/05/2018 – Littelfuse Sees 2Q Adj Effective Tax Rate 19.5%-20.5%; 21/03/2018 – Littelfuse at Management Roadshow Hosted By CL King Today; 26/04/2018 – Littelfuse Presenting at Conference May 10; 02/05/2018 – Littelfuse 1Q Adj EPS $2.39
Hamilton Point Investment Advisors Llc holds 2.51% of its portfolio in Littelfuse, Inc. for 33,266 shares. Summit Creek Advisors Llc owns 72,735 shares or 2.16% of their US portfolio. Moreover, Copeland Capital Management Llc has 1.66% invested in the company for 168,700 shares. The Illinois-based Channing Capital Management Llc has invested 1.35% in the stock. North Point Portfolio Managers Corp Oh, a Ohio-based fund reported 40,835 shares.
More notable recent Littelfuse, Inc. (NASDAQ:LFUS) news were published by: Finance.Yahoo.com which released: “Does Market Volatility Impact Littelfuse, Inc.’s (NASDAQ:LFUS) Share Price? – Yahoo Finance” on October 30, 2019, also Finance.Yahoo.com with their article: “Don’t Ignore The Fact That This Insider Just Sold Some Shares In Littelfuse, Inc. (NASDAQ:LFUS) – Yahoo Finance” published on November 07, 2019, Seekingalpha.com published: “Wall Street Brunch – Seeking Alpha” on November 03, 2019. More interesting news about Littelfuse, Inc. (NASDAQ:LFUS) were released by: Finance.Yahoo.com and their article: “Investors Who Bought Littelfuse (NASDAQ:LFUS) Shares Five Years Ago Are Now Up 86% – Yahoo Finance” published on August 01, 2019 as well as Finance.Yahoo.com‘s news article titled: “Here’s Why We Think Littelfuse (NASDAQ:LFUS) Is Well Worth Watching – Yahoo Finance” with publication date: September 30, 2019.
Analysts await Littelfuse, Inc. (NASDAQ:LFUS) to report earnings on January, 29. They expect $1.14 EPS, down 39.04% or $0.73 from last year’s $1.87 per share. LFUS’s profit will be $27.77M for 40.06 P/E if the $1.14 EPS becomes a reality. After $1.78 actual EPS reported by Littelfuse, Inc. for the previous quarter, Wall Street now forecasts -35.96% negative EPS growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.